IL6 and diabetes mellitus: The presence of a chronic subclinical proinflammatory state has been well-described in the setting of diabetes mellitus as activation of IL-1β, TNF-α, and IL-6 signaling pathways often precedes the onset of diabetes mellitus [34, 35].